According to Axon Enterprise 's latest financial reports the company's current earnings (TTM) are $0.11 B. In 2022 the company made an earning of $93.25 M an increase over its 2021 earnings that were of -$0.17 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.11 B | 19.58% |
2022 | $93.25 M | -155.47% |
2021 | -$0.17 B | 1088.15% |
2020 | -$14.15 M | 121.3% |
2019 | -$6.4 M | -125.74% |
2018 | $24.84 M | 90.75% |
2017 | $13.02 M | -59.11% |
2016 | $31.85 M | -9.86% |
2015 | $35.33 M | 8.71% |
2014 | $32.5 M | 10.67% |
2013 | $29.36 M | 43.34% |
2012 | $20.48 M | -402.82% |
2011 | -$6.77 M | 31.65% |
2010 | -$5.14 M | 6391.49% |
2009 | -$0.08 M | -100.45% |
2008 | $17.46 M | -14.25% |
2007 | $20.37 M | -474.06% |
2006 | -$5.45 M | -431.3% |
2005 | $1.64 M | -94.68% |
2004 | $30.87 M | 307.28% |
2003 | $7.58 M | 1999.86% |
2002 | $0.36 M | -63.88% |
2001 | $0.99 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() XBiotech XBIT | -$34.96 M | -131.34% | ๐บ๐ธ USA |
![]() Sangamo Therapeutics
SGMO | -$0.11 B | -194.97% | ๐บ๐ธ USA |
![]() Flexion Therapeutics
FLXN | -$79.39 M | -171.19% | ๐บ๐ธ USA |
![]() Exelixis EXEL | $0.20 B | 87.67% | ๐บ๐ธ USA |